Health
New antiviral repurposing study finds peptides that could prevent SARS-CoV-2-ACE2 binding – News-Medical.Net
A new study reports the antiviral potential of peptides against SARS-CoV-2’s spike protein.
As the world continues to struggle with the coronavirus disease 2019 (COVID-19) pandemic, researchers are busy searching for pharmaceuticals that can effectively counteract the pathogen. This causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), infects through engagement via its spike protein with the host cell, attaching to the angiotensin-converting enzyme 2 (ACE2) receptor. The spike-ACE2 interaction has thus become a prime target of antiviral strategies.
A new study…
-
Noosa News19 hours agoThe Pedro Pascal-Led Fantastic Four Face Julia Garner’s Silver Surfer in the New Full ‘First Steps’ Trailer
-
General18 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
Noosa News22 hours agoMeet Llew O’Brien, LNP | Noosa Today
-
General19 hours agoPolice say man shot dead in Footscray had charged at officers armed with knife